Author

Vishal Boolell

Observed name: V. Boolell

Institutions: Northern Health, Northern Hospital

Observed institutions: Baker Heart and Diabetes Institute, Northern Health, Monash Medical Centre, Hudson Institute of Medical Research, Northern Hospital, Ballarat Health Services, Monash Health, Western Hospital, Monash University

OpenAlex ID: A5072353228

Pembrolizumab Plus Concurrent Chemoradiation Therapy in Patients With Unresectable, Locally Advanced, Stage III Non–Small Cell Lung Cancer

2021 · Salma K. Jabbour, Ki Hyeong Lee, et al. · JAMA Oncology · 281

The Evolution of Therapies in Non-Small Cell Lung Cancer

2015 · Vishal Boolell, Muhammad Alamgeer, et al. · Cancers · 130

The HMG-CoA reductase inhibitor rosuvastatin and the angiotensin receptor antagonist candesartan attenuate atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes via effects on advanced glycation, oxidative stress and inflammation

2008 · A. C. Calkin, S. Giunti, et al. · Diabetologia · 63

Inhibition of activin signaling in lung adenocarcinoma increases the therapeutic index of platinum chemotherapy

2018 · Kieren D. Marini, David R. Croucher, et al. · Science Translational Medicine · 45

Deep multi-region whole-genome sequencing reveals heterogeneity and gene-by-environment interactions in treatment-naive, metastatic lung cancer

2018 · Tracy L. Leong, Velimir Gayevskiy, et al. · Oncogene · 33

A phase 1 study of CRLX301, a novel nanoparticle-drug conjugate (NDC) containing docetaxel (DOC), in patients with refractory solid tumors.

2016 · Ben Markman, Paul L. De Souza, et al. · Journal of Clinical Oncology · 24

KEYNOTE-799: Phase 2 trial of pembrolizumab plus platinum chemotherapy and radiotherapy for unresectable, locally advanced, stage 3 NSCLC.

2021 · Salma K. Jabbour, Ki Hyeong Lee, et al. · Journal of Clinical Oncology · 18

A phase I dose-escalation study of BGB-A317, an anti-programmed death-1 (PD-1) mAb in patients with advanced solid tumors.

2016 · Jayesh Desai, Ben Markman, et al. · Journal of Clinical Oncology · 6

Pembrolizumab Plus Platinum Chemotherapy and Radiotherapy for Unresectable, Locally Advanced, Stage 3 NSCLC: KEYNOTE-799

2021 · S.K. Jabbour, K.H. Lee, et al. · International Journal of Radiation Oncology*Biology*Physics · 3

Efficacy of late line pertuzumab with trastuzumab and chemotherapy in HER2‐positive metastatic breast cancer: An Australian case series

2019 · Alice R. T. Bergin, Stephen J. Luen, et al. · Asia-Pacific Journal of Clinical Oncology · 2

Identification of Clinical Variation of Interest in Standard of Care Practice in a Statewide Bench Marking Audit of Brain Tumor Patient Care

2025 · Hui K. Gan, Laura Tam, et al. · Asia-Pacific Journal of Clinical Oncology · 1

Pulmonary tumour thrombotic microangiopathy: a rare but underappreciated complication of malignancy

2019 · Pakeeran Siriratnam, Vishal Boolell · The Medical Journal of Australia · 1

Impact of primary tumor stage on survival following resection of metachronous liver and/or lung metastases in colorectal cancer.

2015 · Hui-Li Wong, Vishal Boolell, et al. · Journal of Clinical Oncology · 1

Th-P16:286 Effects of rosuvastatin combined with candesartan on oxidative stress and inflammatory parameters in diabetes accelerated atherosclerosis

2006 · K. Jandeleit-Dahm, Y. Rajaram, et al. · Atherosclerosis Supplements · 1

916P Implementing practice-changing perioperative management of resectable non-small-cell lung cancer at an Australian metropolitan hospital

2025 · G.F. Perez, V. Boolell, et al. · Annals of Oncology

Works count: 15

Citation count: 609

H-index: 7

I10-index: 7